Spread Through Air Spaces in Stage I Pulmonary Large Cell Neuroendocrine Carcinoma
CONCLUSIONS: STAS may serve as an adverse prognostic factor in stage I LCNEC patients, potentially offering guidance for postoperative chemotherapy decisions.PMID:38242341 | DOI:10.1016/j.athoracsur.2024.01.002
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Shiyue Wan Ziyun Shen Shiqi Hu Lele Zhang Huansha Yu Yan Chen Jue Wang Di Wang Jing Zhang Peng Zhang Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Carcinoma | Cardiovascular & Thoracic Surgery | Chemotherapy | Lung Cancer | Neurology | Neurosurgery | Non-Small Cell Lung Cancer | Statistics